MAI Capital Management 13D and 13G filings for PhaseBio Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-07-19 11:30 am Purchase |
2022-07-12 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ |
MAI Capital Management | 2,675,376 5.800% |
2,675,376 (New Position) |
Filing |